Eli Lilly stock rallies as the firm’s oral weight-loss pill, Foundayo, secures FDA approval. Options pricing suggests LLY ...

The pill will be branded as Foundayo and shipping will begin on Monday and be available at pharmacies and on telehealth ...

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

April 1 (Reuters) - The U.S. Food and Drug Administration on Wednesday clarified its policies on compounded versions of ...

CNBC's Angelica Peebles reports the latest news surrounding GLP-1 drugs.

The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.

Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll ...

Eli Lilly's new GLP-1 pill called Foundayo received FDA approval on April 1, making it a new once-daily option for weight ...

The approval sets up a new phase of competition between Eli Lilly and its main competitor, Danish drugmaker Novo Nordisk , in ...

Producers appear to be approaching the issue as part and parcel of the broader growing consumer interest in health and ...